Study: Risk of cancer remains high for women over 50 with genetic BRCA1 or BRCA2 mutation

by University of TorontoCredit: Pixabay/CC0 Public DomainAlthough genetic mutations in BRCA1 or BRCA2 are associated with a younger onset of breast and ovarian cancer, women with these genetic mu

Updated on: February 01,2024

Study: Risk of cancer remains high for women over 50 with genetic BRCA1 or BRCA2 mutation

by University of TorontoCredit: Pixabay/CC0 Public DomainAlthough genetic mutations in BRCA1 or BRCA2 are associated with a younger onset of breast and ovarian cancer, women with these genetic mu

Updated on:February 01,2024

Immune system plays vital role in longer multiple myeloma remission, new study shows

byUniversity of Miami Leonard M. Miller School of MedicineStudy design and treatment outcomes. a Immune profiling was performed on blood and bone marrow collected from 23 patients with multiple

Updated on: January 12,2024

Immune system plays vital role in longer multiple myeloma remission, new study shows

byUniversity of Miami Leonard M. Miller School of MedicineStudy design and treatment outcomes. a Immune profiling was performed on blood and bone marrow collected from 23 patients with multiple

Updated on:January 12,2024

Genetic variation enhances cancer drug sensitivity in specific patient groups, study shows

byUppsala UniversityA graphical summary illustrates the strategy used to identify CYP2D6 as a target for collateral lethality, which is driven by the widespread occurrence of loss of heterozygos

Updated on: December 01,2024

Genetic variation enhances cancer drug sensitivity in specific patient groups, study shows

byUppsala UniversityA graphical summary illustrates the strategy used to identify CYP2D6 as a target for collateral lethality, which is driven by the widespread occurrence of loss of heterozygos

Updated on:December 01,2024

Tackling resistance to HIF2 drugs with an RNA-based therapy

byUT Southwestern Medical CenterDownregulation of HIF2α by ARO-HIF2 in patient tumor biopsies. Credit: Dr. Payal KapurExpected to be diagnosed in 2% of men and 1% of women in the U.S., kidney ca

Updated on: December 28,2023

Tackling resistance to HIF2 drugs with an RNA-based therapy

byUT Southwestern Medical CenterDownregulation of HIF2α by ARO-HIF2 in patient tumor biopsies. Credit: Dr. Payal KapurExpected to be diagnosed in 2% of men and 1% of women in the U.S., kidney ca

Updated on:December 28,2023

Study: Key mechanisms of action differences in immune checkpoint inhibitor combination therapies for advanced melanoma

byH. Lee Moffitt Cancer Center & Research InstituteProposed mechanism of the two ICI combinations. Graphic created with Biorender (biorender.com). ICI, immune checkpoint inhibitor. Credit:&n

Updated on: January 25,2024

Study: Key mechanisms of action differences in immune checkpoint inhibitor combination therapies for advanced melanoma

byH. Lee Moffitt Cancer Center & Research InstituteProposed mechanism of the two ICI combinations. Graphic created with Biorender (biorender.com). ICI, immune checkpoint inhibitor. Credit:&n

Updated on:January 25,2024

Researchers link ovarian cancer to bacteria colonization in microbiome

by Susan Murphy,Mayo Clinicβ-diversities measures were compared. For β-diversity, Bray–Curtis (BC), unweighted, and weighted, UniFrac distance metrics were reported. The most significant metric

Updated on: February 20,2024

Researchers link ovarian cancer to bacteria colonization in microbiome

by Susan Murphy,Mayo Clinicβ-diversities measures were compared. For β-diversity, Bray–Curtis (BC), unweighted, and weighted, UniFrac distance metrics were reported. The most significant metric

Updated on:February 20,2024

Anti-diabetic drugs could lower risk of primary and secondary brain cancer

by University of BristolCredit: CC0 Public DomainDiabetic patients who take anti-diabetic drugs—known as glitazones—long term had a lower risk of primary and secondary brain cancer compared with

Updated on: April 07,2024

Anti-diabetic drugs could lower risk of primary and secondary brain cancer

by University of BristolCredit: CC0 Public DomainDiabetic patients who take anti-diabetic drugs—known as glitazones—long term had a lower risk of primary and secondary brain cancer compared with

Updated on:April 07,2024

'3D mammography' almost halves the incidence of breast cancer between two screening tests in clinical trial

byUniversity of CórdobaDBT interval carcinoma. A 60-year-old asymptomatic patient who underwent a repeat mammographic study 20months after the screening study interpreted as normal due to

Updated on: March 30,2024

'3D mammography' almost halves the incidence of breast cancer between two screening tests in clinical trial

byUniversity of CórdobaDBT interval carcinoma. A 60-year-old asymptomatic patient who underwent a repeat mammographic study 20months after the screening study interpreted as normal due to

Updated on:March 30,2024

Can what works to treat cancer work for diabetes?

by Jess Berthold,University of California, San FranciscoCredit: CC0 Public DomainTo live with type 1 diabetes is to be ruled by relentless routine. Food must be carefully monitored, and the only

Updated on: January 30,2024

Can what works to treat cancer work for diabetes?

by Jess Berthold,University of California, San FranciscoCredit: CC0 Public DomainTo live with type 1 diabetes is to be ruled by relentless routine. Food must be carefully monitored, and the only

Updated on:January 30,2024

Cancer metastasis: Tumor plasticity counts

by Université libre de BruxellesCredit: CC0 Public DomainCancer metastasis, which is the propagation of tumor cells into distant organs, is the leading cause of cancer patient mortality. To under

Updated on: March 12,2024

Cancer metastasis: Tumor plasticity counts

by Université libre de BruxellesCredit: CC0 Public DomainCancer metastasis, which is the propagation of tumor cells into distant organs, is the leading cause of cancer patient mortality. To under

Updated on:March 12,2024

A new combination therapy regimen shows promising results for prostate cancer

by Huntsman Cancer InstituteCredit: CC0 Public DomainTALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progress

Updated on: January 28,2024

A new combination therapy regimen shows promising results for prostate cancer

by Huntsman Cancer InstituteCredit: CC0 Public DomainTALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progress

Updated on:January 28,2024

Researchers pinpoint tumor-related protein, slow progression of cancers

by University of Nebraska-LincolnThe University of Nebraska-Lincoln's Paul Black (left) and Concetta DiRusso have co-authored a new study that could improve the treatment of malignant tumors.

Updated on: June 11,2024

Researchers pinpoint tumor-related protein, slow progression of cancers

by University of Nebraska-LincolnThe University of Nebraska-Lincoln's Paul Black (left) and Concetta DiRusso have co-authored a new study that could improve the treatment of malignant tumors.

Updated on:June 11,2024